Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
1234
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Emerging Infectious Diseases 2010 NIAID 1RC1AI081251-01 Mitigation of Radiation Pneumonopathy By Lignan Action CHRISTOFIDOU-SOLOMIDOU, MELPO UNIVERSITY OF PENNSYLVANIA PA $1,000,000
Emerging Infectious Diseases 2010 NIAID 1RC1AI081273-01 Blockade of the SDF-1/CXCR4 axis as a novel strategy for mitigating radiation-ind SHU, HUI-KUO EMORY UNIVERSITY GA $850,335
Emerging Infectious Diseases 2010 NIAID 1RC1AI081290-01 Antioxidant Mimetic as a Mitigator of Radiation Induced Lung Injury VUJASKOVIC, ZELJKO DUKE UNIVERSITY NC $1,000,000
Emerging Infectious Diseases 2010 NCRR 1S10RR026548-01 FACSAria II Cell Sorter DARZYNKIEWICZ, ZBIGNIEW NEW YORK MEDICAL COLLEGE NY $500,000
Emerging Infectious Diseases 2010 NCRR 1S10RR026697-01 Two-photon microscope for intravital imaging MOTHES, WALTHER YALE UNIVERSITY CT $487,929
Emerging Infectious Diseases 2010 NCRR 1S10RR026478-01 MicroCal Auto-iTC200; automated high sensitivity isothermal titration calorimetry BROUILLETTE, CHRISTIE UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $250,000
Emerging Infectious Diseases 2010 NCRR 1S10RR027037-01 Crystallization Robot for the Structural Biology Resource Center at Rockefeller OREN, DEENA ROCKEFELLER UNIVERSITY NY $147,262
Emerging Infectious Diseases 2010 NCRR 1S10RR026891-01 GE AKTAEXPLORER CHROMOTOGRAPHY SYSTEM ODOM, AUDREY WASHINGTON UNIVERSITY MO $121,776
Emerging Infectious Diseases 2010 NCRR 1S10RR023734-01A1 Laser Scanning Confocal Microscope FEKETE, DONNA PURDUE UNIVERSITY WEST LAFAYETTE IN $499,610
Emerging Infectious Diseases 2010 NCRR 1S10RR025660-01A1 Acquisition of a MALDI-TOF/TOF MS for Glycomic and Lipidomic Research SCHLESINGER, LARRY OHIO STATE UNIVERSITY OH $414,998
Emerging Infectious Diseases 2010 NCRR 1S10RR027143-01 BioMark MX/HX Genetic Analysis System PAPP, JEANETTE UNIVERSITY OF CALIFORNIA LOS ANGELES CA $247,658
Emerging Infectious Diseases 2010 NCRR 1S10RR027197-01 5500 QTRAP TURK, JOHN WASHINGTON UNIVERSITY MO $484,350
Emerging Infectious Diseases 2010 NCRR 1S10RR027616-01 Genome Sequencer FLX Instrument KANE, ANNE TUFTS MEDICAL CENTER MA $493,500
Emerging Infectious Diseases 2010 NIAID 1RC1AI086027-01 A unique approach to identify markers for congenital syphilis and neurosyphilis PARVEEN, NIKHAT UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL NJ $367,600
Emerging Infectious Diseases 2010 NIAID 1RC1AI086597-01 Defensin gene copy number and mucosal innate immunity SOLNICK, JAY UNIVERSITY OF CALIFORNIA DAVIS CA $500,000
Emerging Infectious Diseases 2010 NIAID 5R03AI071992-02 Mechanism and Inhibition of Arginine Deiminase GUO, HUA UNIVERSITY OF NEW MEXICO NM $75,000
Emerging Infectious Diseases 2010 NIAID 5R21AI082398-02 Staphylococcus aureus binds factor H to moderate complement host defense CUNNION, KENJI EASTERN VIRGINIA MEDICAL SCHOOL VA $179,375
Emerging Infectious Diseases 2010 NIAID 5R21AI077805-02 C. elegans as a model for ricin intoxication TUMER, NILGUN RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK NJ $190,840
Emerging Infectious Diseases 2010 NIAID 5R21AI068999-02 Directed Evolution of a Murine Model of Hepatitis C Virus Replication YANG, PRISCILLA HARVARD UNIVERSITY (MEDICAL SCHOOL) MA $254,250
Emerging Infectious Diseases 2010 NIAID 5R21AI078130-02 Assembly of Influenza A viruses TAKIMOTO, TORU UNIVERSITY OF ROCHESTER NY $229,750
Emerging Infectious Diseases 2010 NIAID 5R21AI074922-02 Depots of persistent influenza antigens support protective CD4 T cell memory JELLEY-GIBBS, DAWN TRUDEAU INSTITUTE, INC. NY $279,180
Emerging Infectious Diseases 2010 NIBIB 5R21EB009550-02 Ultra Rapid Monitoring of Bacterial Nano-Growth and Antibiotic Susceptibility KOPELMAN, RAOUL UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $188,018
Emerging Infectious Diseases 2010 NIAID 5R01AI050618-08 Regulation of Type1 Immunity to Toxoplasma YAP, GEORGE UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL NJ $390,000
Emerging Infectious Diseases 2010 NIAID 5R21AI076893-02 Characterizing the role of the 22 up-regulated genes in mosquito resistance LIU, NANNAN AUBURN UNIVERSITY AT AUBURN AL $255,500
Emerging Infectious Diseases 2010 NIAID 5R21AI073703-02 Proteomics of HCV Replication Complex PANDEY, VIRENDRA UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL NJ $234,000
Emerging Infectious Diseases 2010 NIAID 5R01AI050537-08 Interaction of Sindbis Virus with Cellular Processes FROLOV, ILYA UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $362,588
Emerging Infectious Diseases 2010 NIAID 5R01AI074673-02 Echinocandin Resistance in Aspergillus MAY, GREGORY UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $385,000
Emerging Infectious Diseases 2010 NIAID 5R21AI064190-02 Sodium bioenergetics in Yersinia pestis HASE, CLAUDIA OREGON STATE UNIVERSITY OR $219,300
Emerging Infectious Diseases 2010 NIAID 1RC1AI086730-01 Measuring whole genome expression, cell by cell: bistability in Vibrio cholerae SCHOOLNIK, GARY STANFORD UNIVERSITY CA $482,861
Emerging Infectious Diseases 2010 NIAID 1RC1AI087257-01 Mucosal Immunity and Influenza Vaccines: Phenotype and Role of Activated B Cells BUTCHER, EUGENE PALO ALTO INSTITUTE FOR RES & EDU, INC. CA $491,771
Emerging Infectious Diseases 2010 NIAID 1RC1AI086830-01 Prediction of influenza antigenic variants using a novel sparse multitask learnin WAN, XIU-FENG MISSISSIPPI STATE UNIVERSITY MS $412,913
Emerging Infectious Diseases 2010 NIAID 5R01AI080828-02 The Mechanism of Interferon Regulatory Factor (IRF) Activation PRIVALOV, PETER JOHNS HOPKINS UNIVERSITY MD $403,596
Emerging Infectious Diseases 2010 NIAID 5R01AI021903-26 DRUG RESISTANCE AND PTERIDINE METABOLISM IN LEISHMANIA BEVERLEY, STEPHEN WASHINGTON UNIVERSITY MO $430,481
Emerging Infectious Diseases 2010 NIAID 5R21AI082826-02 Development of a Highly Sensitive Cell-Based Assay for Botulinum Neurotoxin JOHNSON, ERIC UNIVERSITY OF WISCONSIN MADISON WI $222,750
Emerging Infectious Diseases 2010 NIAID 5R21AI078092-02 Salmonella SopA is a functional mimicry of eukaryotic E3 protein ubiquitin ligase ZHOU, DAOGUO PURDUE UNIVERSITY WEST LAFAYETTE IN $190,625
Emerging Infectious Diseases 2010 NIAID 5R21AI073385-02 Virulence Factors of Francisella tularensis MANN, BARBARA UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $189,375
Emerging Infectious Diseases 2010 NIAID 5R21AI081101-02 Antibiotic pressure and selection of TCA cycle mutants in Staphylococcus epidermi FEY, PAUL UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $218,922
Emerging Infectious Diseases 2010 NIAID 5R01AI074693-02 Fimbrial expression in Salmonella: regulation and coordination CLEGG, STEVEN UNIVERSITY OF IOWA IA $375,900
Emerging Infectious Diseases 2010 NIAID 5R01AI075092-03 Mycobacterial Siderophores: Assembly, Assembly Inhibition, and Role in Virulence QUADRI, LUIS BROOKLYN COLLEGE NY $417,719
Emerging Infectious Diseases 2010 NIAID 5R03AI078129-02 Characterization of gene cluster for glycophosphoinositides of mycobacteria KAUR, DEVINDER COLORADO STATE UNIVERSITY-FORT COLLINS CO $73,500
Emerging Infectious Diseases 2010 NIAID 5R01AI057086-07 Cell Biology of Mycobacterium Tuberculosis Infection RUSSELL, DAVID CORNELL UNIVERSITY ITHACA NY $408,779
Emerging Infectious Diseases 2010 NIAID 5R21AI079724-02 Molecular basis of defective CD8 T cells during chronic viral infection SHEN, HAO UNIVERSITY OF PENNSYLVANIA PA $236,250
Emerging Infectious Diseases 2010 NIAID 5R01AI071881-02 Drug Targets for Tuberculosis RUBIN, ERIC HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) MA $395,514
Emerging Infectious Diseases 2010 NCRR 1S10RR028863-01 Computing Infrastructure to Advance Biomedical Research FURLANI, THOMAS STATE UNIVERSITY OF NEW YORK AT BUFFALO NY $2,566,410
Emerging Infectious Diseases 2010 NCRR 1S10RR029249-01 DYNAMIC NUCLEAR POLARIZATION SOLID STATE NMR SPECTROMETER FOR BIOMOLECULAR STUDIE MCDERMOTT, ANN NEW YORK STRUCTURAL BIOLOGY CENTER NY $2,309,300
Emerging Infectious Diseases 2010 NCRR 1S10RR029602-01 iCyt Reflection Cell Sorter KAECH, SUSAN YALE UNIVERSITY CT $898,724
Emerging Infectious Diseases 2010 NCRR 1S10RR029687-01 Ibis T-6,000 Biosensor System SEARS, CYNTHIA JOHNS HOPKINS UNIVERSITY MD $641,500
Emerging Infectious Diseases 2010 NIAID 5R01AI019838-25 Molecular Genetics of HSV DNA Polymerase Gene COEN, DONALD HARVARD UNIVERSITY (MEDICAL SCHOOL) MA $423,750
Emerging Infectious Diseases 2010 NIAID 5R21AI079322-02 Type I interferon-induced protection from staphylococcal pore-forming toxins YAROVINSKY, TIMUR YALE UNIVERSITY CT $248,250
Emerging Infectious Diseases 2010 NIAID 5R21AI079483-02 CRASP-2 proteins of Lyme disease Borrelia STEVENSON, BRIAN UNIVERSITY OF KENTUCKY KY $183,125
Emerging Infectious Diseases 2010 NIAID 5R01AI080709-02 Transport and Insertion of Outer Membrane Proteins SOUSA, MARCELO UNIVERSITY OF COLORADO AT BOULDER CO $370,398
Emerging Infectious Diseases 2010 NIAID 5R01AI055540-07 Therapeutics to Prevent/Treat Lassa Fever Virus OLDSTONE, MICHAEL SCRIPPS RESEARCH INSTITUTE CA $474,750
Emerging Infectious Diseases 2010 NIAID 5R21AI076864-02 Activation of NKT cells by cytomegalovirus BENEDICT, CHRISTOPHER LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $236,125
Emerging Infectious Diseases 2010 NIAID 5R21AI076258-02 West Nile Virus Infection: Novel Genetic Screens to Identify Important Host Genes GLASER, ROBERT WADSWORTH CENTER NY $165,510
Emerging Infectious Diseases 2010 NIAID 5R21AI070792-02 The West Nile virus methyltransferase LI, HONGMIN WADSWORTH CENTER NY $185,552
Emerging Infectious Diseases 2010 NIAID 5R21AI076773-02 Genomic-based diagnostics for Coccidioides the causative agent of Valley fever KEIM, PAUL TRANSLATIONAL GENOMICS RESEARCH INST AZ $207,506
Emerging Infectious Diseases 2010 NIAID 5R21AI079711-02 An Attenuated E.coli Vaccine for Enterotoxigenic E.coli (ETEC) BOEDEKER, EDGAR UNIVERSITY OF NEW MEXICO NM $225,000
Emerging Infectious Diseases 2010 NIAID 5R21AI080788-02 Helicobacter pylori and the gastric microbial community in rhesus macaques SOLNICK, JAY UNIVERSITY OF CALIFORNIA DAVIS CA $191,250
Emerging Infectious Diseases 2010 NIAID 5R21AI082386-02 Role of RepX Protein in Replication/Partitioning of Anthrax Toxin Plasmid pXO1 KHAN, SALEEM UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $227,250
Emerging Infectious Diseases 2010 NIAID 5R21AI081989-02 Creation of a tissue culture model for Toxoplasma gondii sexual development KNOLL, LAURA UNIVERSITY OF WISCONSIN MADISON WI $181,745
Emerging Infectious Diseases 2010 NIAID 5R01AI037787-12 Immune evasion mechanisms of the Borrelia MARCONI, RICHARD VIRGINIA COMMONWEALTH UNIVERSITY VA $355,435
Emerging Infectious Diseases 2010 NIAID 5R21AI075015-02 Proteome-wide identification of RNA-binding proteins KAO, CHENG INDIANA UNIVERSITY BLOOMINGTON IN $196,377
Emerging Infectious Diseases 2010 NIAID 5R01AI072287-02 Autocrine control of neutrophil chemotaxis JUNGER, WOLFGANG BETH ISRAEL DEACONESS MEDICAL CENTER MA $383,000
Emerging Infectious Diseases 2010 NIAID 5R21AI078125-02 Role of Coxiella burnetii group I introns in growth modulation MINNICK, MICHAEL UNIVERSITY OF MONTANA MT $194,563
Emerging Infectious Diseases 2010 NIAID 5R01AI071107-02 Recognition of host catecholamines in Borrelia burgdorferi gene regulation HU, LINDEN TUFTS MEDICAL CENTER MA $322,000
Emerging Infectious Diseases 2010 NIAID 7R21AI076797-02 A Heterologous Expression System for Apicomplexa Genes FERNANDEZ-ROBLEDO, JOSE UNIVERSITY OF MARYLAND BALTIMORE MD $180,903
Emerging Infectious Diseases 2010 NIAID 5R21AI082026-02 THE ROLE OF CELL SHAPE AND CELL WALL IN HELICOBACTER PYLORI PATHOGENESIS SALAMA, NINA FRED HUTCHINSON CANCER RESEARCH CENTER WA $256,210
Emerging Infectious Diseases 2010 NIAID 5R21AI081150-02 Determining how adjuvants alter effector and memory T cells during vaccination KAECH, SUSAN YALE UNIVERSITY CT $193,817
Emerging Infectious Diseases 2010 NIAID 5R01AI076278-02 Innate immune response to bacterial flagellans MCSORLEY, STEPHEN UNIVERSITY OF MINNESOTA TWIN CITIES MN $377,492
Emerging Infectious Diseases 2010 NIAID 5R21AI078532-02 Hepatitis C virus and liver fibrogenesis WARIS, GULAM ROSALIND FRANKLIN UNIV OF MEDICINE & SCI IL $231,000
Emerging Infectious Diseases 2010 NIAID 5R01AI070949-02 Molecular Mechanisms of Salmonella typhi Pathogenicity GALAN, JORGE YALE UNIVERSITY CT $315,946
Emerging Infectious Diseases 2010 NCI 5R21CA133770-02 Metabolomics-based Identification of Hepatocellular Cancer Biomarkers RAFTERY, DANIEL PURDUE UNIVERSITY WEST LAFAYETTE IN $164,671
Emerging Infectious Diseases 2010 NINDS 5R03NS065333-02 Structural basis of species-specific infectivities of two prion strains TESSIER, PETER RENSSELAER POLYTECHNIC INSTITUTE NY $71,663
Emerging Infectious Diseases 2010 NIAID 5R01AI048088-07 Regulation of West Nile virus replication. BRINTON, MARGO GEORGIA STATE UNIVERSITY GA $289,000
Emerging Infectious Diseases 2010 NCI 5R21CA127022-02 Protein Biomarkers of Gastric Cancer REYES, VICTOR UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $166,098
Emerging Infectious Diseases 2010 NHLBI 5R21HL092814-02 Biomimetic Approach to the Fabrication of Red Blood Cell Mimics DESIMONE, JOSEPH UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $361,994
Emerging Infectious Diseases 2010 NIA 5R21AG033825-02 "Aging, Immunization, and TH17 Immunity in Host Defense" HIGH, KEVIN WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $158,571
Emerging Infectious Diseases 2010 NCI 5R21CA129776-02 Intracellular immunization strategy in inhibit HCV related liver cancer DASH, SRIKANTA TULANE UNIVERSITY OF LOUISIANA LA $167,288
Emerging Infectious Diseases 2010 NIAID 5R21AI073808-02 Microfluidic platform for rapid influenza subtyping TRIPATHI, ANUBHAV BROWN UNIVERSITY RI $187,179
Emerging Infectious Diseases 2010 NIAID 5R01AI052781-07 Genetics of Cryptosporidium parvum WIDMER, GIOVANNI TUFTS UNIVERSITY BOSTON MA $326,700
Emerging Infectious Diseases 2010 NIAID 5R03AI081102-02 Ecological population structure and emergence of virulent Vibrio parahaemolyticus COOPER, VAUGHN UNIVERSITY OF NEW HAMPSHIRE NH $69,969
Emerging Infectious Diseases 2010 NIAID 5R21AI068837-02 Development of a recombinant Nipah virus vaccine for wildlife FABER, MILOSZ THOMAS JEFFERSON UNIVERSITY PA $231,750
Emerging Infectious Diseases 2010 NIAID 5R21AI082370-02 In Vivo Function of TRAF6 As a Target of K63-Linked Polyubiquitination BALLARD, DEAN VANDERBILT UNIVERSITY TN $232,500
Emerging Infectious Diseases 2010 NIAID 5R21AI081388-02 Bat rabies virus in its natural host SCHNELL, MATTHIAS THOMAS JEFFERSON UNIVERSITY PA $208,532
Emerging Infectious Diseases 2010 NIAID 5R21AI080797-02 Mechanism of murine coronavirus induced hepatitis WEISS, SUSAN UNIVERSITY OF PENNSYLVANIA PA $236,250
Emerging Infectious Diseases 2010 NIAID 5R01AI058145-05 Novel Azole Resistance Mechanisms in Candida albicans ROGERS, P UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $370,000
Emerging Infectious Diseases 2010 NIAID 5R21AI078143-02 Inhibition of Tap-mediated RNA export by the influenza A viral protein NS1 LEVESQUE, LYNE UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN IL $190,656
Emerging Infectious Diseases 2010 NIAID 5R21AI076249-02 Mechanisms of the Type III Secretion TANG, LIANG UNIVERSITY OF KANSAS LAWRENCE KS $183,750
Emerging Infectious Diseases 2010 NIAID 5R21AI082000-02 Proteome-wide screen for M. tuberculosis antigens HUSSON, ROBERT CHILDREN'S HOSPITAL BOSTON MA $203,230
Emerging Infectious Diseases 2010 NIAID 5R03AI079546-02 Overwintering mortality of nymphal Ixodes scapularis, Lyme disease vector, in a c OSTFELD, RICHARD INSTITUTE OF ECOSYSTEM STUDIES NY $75,332
Emerging Infectious Diseases 2010 NIAID 5R21AI082046-02 In vivo effects of anthrax toxins:imaging host response & bacterial proliferation GLOMSKI, IAN UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $189,168
Emerging Infectious Diseases 2010 NIAID 5R01AI050032-08 Biofilm Development by Vibrio cholerae WATNICK, PAULA CHILDREN'S HOSPITAL BOSTON MA $386,063
Emerging Infectious Diseases 2010 NIAID 5R01AI073774-02 Regulation of Apoptotic Envelope Formation by MTB in the Host Macrophage REMOLD, HEINZ BRIGHAM AND WOMEN'S HOSPITAL MA $445,000
Emerging Infectious Diseases 2010 NIAID 5R21AI082409-02 Selection of RNA aptamers against Ebola virus GP2 MAURY, WENDY UNIVERSITY OF IOWA IA $236,850
Emerging Infectious Diseases 2010 NIAID 5R01AI071193-02 Innate Intracellular Mechanisms BARBER, GLEN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $126,225
Emerging Infectious Diseases 2010 NIAID 5R21AI076142-02 Pathogenesis of HCV in a Novel Mouse Model SU, LISHAN UNIVERSITY OF NORTH CAROLINA CHAPEL HILL NC $185,000
Emerging Infectious Diseases 2010 NIAID 5R21AI076569-02 DNA recombinational repair in Helicobacter pylori WANG, GE UNIVERSITY OF GEORGIA (UGA) GA $222,750
Emerging Infectious Diseases 2010 NIAID 5R01AI047519-12 Cellular Immunity and the Outcome of Hepatitis C Virus Infection CHANG, KYONG-MI UNIVERSITY OF PENNSYLVANIA PA $315,000
Emerging Infectious Diseases 2010 NIAID 5R01AI075164-02 Modulation of T Cell Responses with Cytokines SURH, CHARLES SCRIPPS RESEARCH INSTITUTE CA $474,750
Emerging Infectious Diseases 2010 NIAID 5R21AI080916-02 Hepatitis C virus E2 glycoprotein LAW, MANSUN SCRIPPS RESEARCH INSTITUTE CA $237,375
Emerging Infectious Diseases 2010 NIAID 5R01AI020723-25 Genetic Analysis of S. Pyogenes Virulence Factors SCOTT, JUNE EMORY UNIVERSITY GA $482,503
Emerging Infectious Diseases 2010 NIAID 5R21AI076533-02 A unique mouse model for studying immunity to virulent Franciscella infections KLIMPEL, GARY UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $226,500
Emerging Infectious Diseases 2010 NIAID 5R21AI078148-02 A Genetic Analysis of Pneumotropism and Pneumovirulence in an MHV-1 Model of Sars LEIBOWITZ, JULIAN TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR TX $224,284
Emerging Infectious Diseases 2010 NIAID 5R21AI081071-02 Development of live attenuated influenza virus vaccine NAYAK, DEBI UNIVERSITY OF CALIFORNIA LOS ANGELES CA $192,500
Emerging Infectious Diseases 2010 NIAID 5R01AI061528-06 Biosynthesis Approach to Novel Bioactive Aminocyclitols MAHMUD, TAIFO OREGON STATE UNIVERSITY OR $292,400
Emerging Infectious Diseases 2010 NIAID 5R21AI079457-02 The role of the host Ca/Mn pump in emergence of novel viral RNA recombinants NAGY, PETER UNIVERSITY OF KENTUCKY KY $208,500
Emerging Infectious Diseases 2010 NIAID 5R01AI041111-12 TH1 and TH2 Responses in Viral Immunity MORAN, THOMAS MOUNT SINAI SCHOOL OF MEDICINE NY $381,375
Emerging Infectious Diseases 2010 NIAID 5R01AI079021-02 Inhibitors of c-di-GMP synthesis and degradation LORY, STEPHEN HARVARD UNIVERSITY (MEDICAL SCHOOL) MA $296,625
Emerging Infectious Diseases 2010 NCI 5R21CA138163-02 MANIPULATION OF KINASE ACTIVITY BY KSHV LANA HAYWARD, S JOHNS HOPKINS UNIVERSITY MD $180,400
Emerging Infectious Diseases 2010 NCI 5R21CA141038-02 Escherichia coli and Colorectal Carcinogenesis DONNENBERG, MICHAEL UNIVERSITY OF MARYLAND BALTIMORE MD $165,000
Emerging Infectious Diseases 2010 NIAID 5R21AI081025-02 Anti-MRSA activity of a Bacillus pumilus natural isolate NAKANO, MICHIKO OREGON HEALTH AND SCIENCE UNIVERSITY OR $192,500
Emerging Infectious Diseases 2010 NIAID 5R03AI079297-02 Culture and Identification of Rickettsia-like Organisms in Maryland NORRIS, DOUGLAS JOHNS HOPKINS UNIVERSITY MD $82,000
Emerging Infectious Diseases 2010 NIAID 5R01AI081705-02 Targeting type II secretion, a common virulence pathway SANDKVIST, MARIA UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $379,961
Emerging Infectious Diseases 2010 NIAID 5R21AI081220-02 Molecular and Informatics methods for whole-genome mutational profiling GUBBELS, MARC-JAN BOSTON COLLEGE MA $234,750
Emerging Infectious Diseases 2010 NIAID 5R01AI068799-02 Development of a multivalent vaccine for mouse reservoirs of deer tick pathogens HU, LINDEN TUFTS MEDICAL CENTER MA $310,829
Emerging Infectious Diseases 2010 NIAID 5R03AI076900-02 Transcription antitermination by OB-fold family proteins PHADTARE, SANGITA UNIV OF MED/DENT NJ-R W JOHNSON MED SCH NJ $78,000
Emerging Infectious Diseases 2010 NIAID 7R01AI076534-02 CD4 effector contraction in influenza SWAIN, SUSAN UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $411,146
Emerging Infectious Diseases 2010 NIAID 5R03AI080807-02 High Throughput Screening: Bacterial Mechanosensitive Channels as Drug Targets BLOUNT, PAUL UNIVERSITY OF TEXAS SW MED CTR/DALLAS TX $78,500
Emerging Infectious Diseases 2010 NIAID 5R21AI073322-02 Use of Molecular Hydrogen by Salmonella typhimurium MAIER, ROBERT UNIVERSITY OF GEORGIA (UGA) GA $222,750
Emerging Infectious Diseases 2010 NIAID 5R01AI049294-09 Organization and function of a type II secretion complex SANDKVIST, MARIA UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $380,179
Emerging Infectious Diseases 2010 NIAID 5R21AI078136-02 Interaction between Vibrio cholerae and Dictylostelium discoideum PAYNE, SHELLEY UNIVERSITY OF TEXAS AUSTIN TX $186,360
Emerging Infectious Diseases 2010 NIAID 5R21AI082399-02 Does Dengue Virus Suppress RNA Interference in its Mosquito Vector? HANLEY, KATHRYN NEW MEXICO STATE UNIVERSITY LAS CRUCES NM $146,200
Emerging Infectious Diseases 2010 NIAID 5R01AI082423-02 DEVELOPING KINASE INHIBITORS TO COUNTERACT PARASITE VIRULENCE SIBLEY, L WASHINGTON UNIVERSITY MO $379,301
Emerging Infectious Diseases 2010 NIAID 5R01AI053615-07 Mechanism for activation of the antiviral kinase PKR COLE, JAMES UNIVERSITY OF CONNECTICUT STORRS CT $306,000
Emerging Infectious Diseases 2010 NIAID 5R01AI055962-07 Inhibition of T Cell Responses by Bacteria STARNBACH, MICHAEL HARVARD UNIVERSITY (MEDICAL SCHOOL) MA $412,987
Emerging Infectious Diseases 2010 NIAID 5R01AI050848-08 The function of CARD9 in innate immune responses LIN, XIN UNIVERSITY OF TEXAS MD ANDERSON CAN CTR TX $346,500
Emerging Infectious Diseases 2010 NIAID 5R21AI083389-02 Hepatic Lipase and HCV Infection WANG, TIANYI UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $186,106
Emerging Infectious Diseases 2010 NIAID 5R01AI055607-07 Persistence of West Nile virus in California REISEN, WILLIAM UNIVERSITY OF CALIFORNIA DAVIS CA $548,026
Emerging Infectious Diseases 2010 NIAID 5R21AI081970-02 The Role of Sigma Factor B in Staphylococcus aureus biofilm development HORSWILL, ALEXANDER UNIVERSITY OF IOWA IA $224,247
Emerging Infectious Diseases 2010 NIAID 5R21AI082027-02 Role of Pin-domain toxins in Mycobacterium tuberculosis pathogenesis BUTLER, JAMES UNIVERSITY OF ROCHESTER NY $210,489
Emerging Infectious Diseases 2010 NIAID 5R21AI082242-02 Catalytic inactivation of miRNA function by customized RNase P-based ribozymes SCHOENBERG, DANIEL OHIO STATE UNIVERSITY OH $269,571
Emerging Infectious Diseases 2010 NIAID 5R21AI080965-02 Multivalent VAccines for Biodefense SCHNEEMANN, ANETTE SCRIPPS RESEARCH INSTITUTE CA $261,113
Emerging Infectious Diseases 2010 NIAID 5R01AI075272-02 Mutational Analysis of Fks1: Intrinsic Echinocandin Resistance EDLIND, THOMAS DREXEL UNIVERSITY PA $269,354
Emerging Infectious Diseases 2010 NIAID 5R21AI064333-02 Live Oral Listeria Vaccine Vector ORNDORFF, PAUL NORTH CAROLINA STATE UNIVERSITY RALEIGH NC $212,373
Emerging Infectious Diseases 2010 NIAID 5R21AI080960-02 Evaluation of Protein Channel-Attenuated Salmonella Vaccines YANG, XINGHONG MONTANA STATE UNIVERSITY (BOZEMAN) MT $178,125
Emerging Infectious Diseases 2010 NIAID 5R21AI076943-02 Sulfur Assimilation Pathway: New Antifungal Targets NEWPORT, GEORGE UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $192,649
Emerging Infectious Diseases 2010 NIAID 5R21AI063014-02 Role of ISG12 in cellular innate immune responses LEAMAN, DOUGLAS UNIVERSITY OF TOLEDO OH $181,875
Emerging Infectious Diseases 2010 NHLBI 5R01HL067286-07 Novel antibacterial agents resistant to inactivation by polyelectrolytes JANMEY, PAUL UNIVERSITY OF PENNSYLVANIA PA $451,390
Emerging Infectious Diseases 2010 NIDA 5R03DA025977-02 Decision Making and Drug Abuse in the Chicago MACS MARTIN, EILEEN UNIVERSITY OF ILLINOIS AT CHICAGO IL $157,000
Emerging Infectious Diseases 2010 NIAID 1RC2AI087580-01 Bioactive Peptides for Mitigation of AGS and Acute Radiation Injury ZHANG, LURONG UNIVERSITY OF FLORIDA FL $499,155
Emerging Infectious Diseases 2010 NIAID 1RC2AI087591-01 A gene therapy for bacterial translocation in mice with whole body irradiation SUZUKI, FUJIO UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $549,708
Emerging Infectious Diseases 2010 NIDCR 5R03DE019179-02 Contribution of the Streptococcus mutans cid and lrg Murein Hydrolase Regulator H RICE, KELLY UNIVERSITY OF FLORIDA FL $109,875
Emerging Infectious Diseases 2010 NIAID 5R21AI083855-02 Dissection of Mycobacterium tuberculosis metabolic and regulatory pathways to per SHI, LANBO UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL NJ $195,000
Emerging Infectious Diseases 2010 NIAID 5R21AI083897-02 Determining vaccine candidacy of LT and STa toxoid fusions against enterotoxigeni ZHANG, WEIPING SOUTH DAKOTA STATE UNIVERSITY SD $206,632
Emerging Infectious Diseases 2010 NIAID 5R21AI083482-02 Role of TLR4 in Coronavirus Infection VARGA, STEVEN UNIVERSITY OF IOWA IA $186,600
Emerging Infectious Diseases 2010 NIAID 5R21AI072401-02 E. coli Growth Parameters in the Intestine CONWAY, TYRRELL UNIVERSITY OF OKLAHOMA NORMAN OK $187,501
Emerging Infectious Diseases 2010 NIAID 5R03AI083254-02 Vector Surveillance Ontology and Vector Management Ontology EISEN, LARS COLORADO STATE UNIVERSITY-FORT COLLINS CO $73,500
Emerging Infectious Diseases 2010 NIAID 5R21AI072752-02 Virus interference with Toll like Receptor Response on Dendritic Cells ZUNIGA, ELINA UNIVERSITY OF CALIFORNIA SAN DIEGO CA $187,675
Emerging Infectious Diseases 2010 NIAID 5R01AI075298-02 Immune cell dynamics during central nervous system viral infection DE LA TORRE, JUAN SCRIPPS RESEARCH INSTITUTE CA $459,450
Emerging Infectious Diseases 2010 NIAID 5R21AI080984-02 Determinants of Pathogenic Hantavirus Attachment MACKOW, ERICH STATE UNIVERSITY NEW YORK STONY BROOK NY $196,146
Emerging Infectious Diseases 2010 NIAID 5R21AI080959-02 Innate Immune Sensing of Microbial Viability BLANDER, JULIE MAGARIAN MOUNT SINAI SCHOOL OF MEDICINE NY $254,250
Emerging Infectious Diseases 2010 NIAID 5R21AI079360-02 CIRCADIAN REGULATION OF INNATE IMMUNE MECHANISMS OF VIRAL RECOGNITION FIKRIG, EROL YALE UNIVERSITY CT $206,875
Emerging Infectious Diseases 2010 NIAID 5R21AI076705-02 Tick Midgut Proteins Critical for Borrelia Transmission NARASIMHAN, SUKANYA YALE UNIVERSITY CT $248,250
Emerging Infectious Diseases 2010 NIAID 5R21AI076987-02 Sp1 As a Novel Protective Mechanism Against Septic inflammation And Organ Injury. LIU, SHU FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH NY $287,595
Emerging Infectious Diseases 2010 NIAID 5R21AI082331-02 Improved plague vaccine by targeting dendritic cell subsets DO, YOONKYUNG ROCKEFELLER UNIVERSITY NY $253,500
Emerging Infectious Diseases 2010 NIAID 5R21AI076697-02 Epidemic Typhus Pathogenesis SAHNI, SANJEEV UNIVERSITY OF ROCHESTER NY $229,625
Emerging Infectious Diseases 2010 NIAID 5R21AI083936-02 Predicting Protein Evolution with Phage Escape DICKERSON, TOBIN SCRIPPS RESEARCH INSTITUTE CA $237,375
Emerging Infectious Diseases 2010 NIAID 5R21AI083555-02 "Innate Immune Lymphocytes and the Gut Epithelium" SOLOSKI, MARK JOHNS HOPKINS UNIVERSITY MD $205,000
Emerging Infectious Diseases 2010 NIAID 5R21AI079482-02 Identification of Francisella tularensis extracellular proteins expressed in vivo BINA, JAMES UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $222,000
Emerging Infectious Diseases 2010 NIAID 5R21AI079358-02 A model to study human TLR9 function in mice BARTON, GREGORY UNIVERSITY OF CALIFORNIA BERKELEY CA $220,332
Emerging Infectious Diseases 2010 NIAID 5R03AI083796-02 Loading Skin-Derived Antigen on Dendritic Cells in Vivo for T Responses in Vitro CAMPBELL, JAMES BRIGHAM AND WOMEN'S HOSPITAL MA $78,669
Emerging Infectious Diseases 2010 NIAID 5R01AI078277-02 Control of Macrophage Responses to Borrelia Burgdorferi by IFNg ANGUITA, JUAN UNIVERSITY OF MASSACHUSETTS AMHERST MA $309,750
Emerging Infectious Diseases 2010 NIAID 5R01AI050810-08 Immunological control of a persistent viral infection SARAWAR, SALLY TORREY PINES INST FOR MOLECULAR STUDIES CA $450,000
Emerging Infectious Diseases 2010 NIAID 5R21AI079342-02 Gender Factors Influencing Susceptability to Influenza KLEIN, SABRA JOHNS HOPKINS UNIVERSITY MD $205,000
Emerging Infectious Diseases 2010 NIAID 5R21AI076764-02 Beta-Defensins: Mediators of Gastrointestinal Inflammation COHN, STEVEN UNIVERSITY OF VIRGINIA CHARLOTTESVILLE VA $189,375
Emerging Infectious Diseases 2010 NIAID 5R03AI079638-02 Methyltransferase inhibition assay development WEISBLUM, BERNARD UNIVERSITY OF WISCONSIN MADISON WI $74,250
Emerging Infectious Diseases 2010 NIAID 5R03AI079478-02 PPK Dependent Acidocalcisome-like Granules, Polyphosphates and Helicobacter SEUFFERHELD, MANFREDO UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN IL $71,826
Emerging Infectious Diseases 2010 NIAID 5R21AI076937-02 Evasion of antiviral protection by poxvirus-encoded interferon antagonists KOTENKO, SERGEI UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL NJ $234,000
Emerging Infectious Diseases 2010 NIAID 5R21AI082335-02 Effect of ESAT-6 on human T cell Function SAMTEN, BUKA UNIVERSITY OF TEXAS HLTH CTR AT TYLER TX $176,250
Emerging Infectious Diseases 2010 NIAID 5R03AI077590-02 Molecular Mechanisms of L. monocytogenes Adhesion Through Surface Biopolymers ABU-LAIL, NEHAL WASHINGTON STATE UNIVERSITY WA $70,175
Emerging Infectious Diseases 2010 NIAID 5R21AI082509-02 UBIQUITIN AND CELLULAR FACTORS IN CORONAVIRUS ASSEMBLY GALLAGHER, THOMAS LOYOLA UNIVERSITY CHICAGO IL $186,875
Emerging Infectious Diseases 2010 NIAID 5R21AI083539-02 Mucosal TGF-Beta/IL-6 Axis in the Regulation of T Cell Function SMYTHIES, LESLEY UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $183,125
Emerging Infectious Diseases 2010 NIAID 5R21AI083422-02 Role of the neurogenic inflammatory pathway in the genital tract immune response RANK, ROGER ARKANSAS CHILDREN'S HOSPITAL RES INST AR $202,125
Emerging Infectious Diseases 2010 NIAID 5R03AI083820-02 Generation of complement C9 conditional knockout mice and anti-C9 mAbs BARNUM, SCOTT UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $73,250
Emerging Infectious Diseases 2010 NINDS 5R21NS065260-02 Innate Immune Mechanisms of Motor Neuron Injury VARTANIAN, TIMOTHY BETH ISRAEL DEACONESS MEDICAL CENTER MA $212,500
Emerging Infectious Diseases 2010 NIAID 5R21AI076753-02 Biosynthesis & Function of a Bacillus anthracis-specific cell wall polysaccharide CARLSON, RUSSELL UNIVERSITY OF GEORGIA (UGA) GA $185,625
Emerging Infectious Diseases 2010 NIAID 5R21AI083673-02 INHIBITION OF INFLUENZA VIRUS NS1 FUNCTION BY SMALL MOLECULES SHAW, MEGAN MOUNT SINAI SCHOOL OF MEDICINE NY $211,875
Emerging Infectious Diseases 2010 NIAID 5R21AI083328-02 Mucosal adjuvants regulate inflammation and immunity RAZ, EYAL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $193,125
Emerging Infectious Diseases 2010 NIAID 5R01AI058106-08 TLR2 in Sepsis-Induced Coagulopathy, Endothelial Leak, and Pulmonary Dysfunction HELLMAN, JUDITH UNIVERSITY OF CALIFORNIA SAN FRANCISCO CA $345,173
Emerging Infectious Diseases 2010 NIAID 5R01AI047294-12 Molecular and Force Dynamics: Leukocyte Adhesion Molecules SIMON, SCOTT UNIVERSITY OF CALIFORNIA DAVIS CA $374,712
Emerging Infectious Diseases 2010 NIDA 5R21DA026773-02 Reduction of Medical Complications associated with Injection Drug Use PHILLIPS, KRISTINA UNIVERSITY OF NORTHERN COLORADO CO $178,283
Emerging Infectious Diseases 2010 NIAID 5R01AI062415-07 Inhibitors of latent M. tuberculosis LEE, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $528,883
Emerging Infectious Diseases 2010 NIAID 1RC2AI087612-01 Stem Cell Based Therapy For Radiation Induced Gastrointestinal Syndrome GUHA, CHANDAN ALBERT EINSTEIN COL OF MED YESHIVA UNIV NY $578,200
Emerging Infectious Diseases 2010 NCI 5R01CA082312-10 Bacterial and Chemical Carcinogens in Gastric Oncogenesis DUBOIS, ANDRE HENRY M. JACKSON FDN FOR THE ADV MIL/MED MD $336,205
Emerging Infectious Diseases 2010 NIAID 5R03AI083736-02 Novel Antibacterial Drugs Targeting DNA Repair Enzymes SMITH, GERALD FRED HUTCHINSON CANCER RESEARCH CENTER WA $88,000
Emerging Infectious Diseases 2010 NIAID 5R21AI081090-02 Nanostructured in vitro TB latency model TIMMINS, GRAHAM UNIVERSITY OF NEW MEXICO NM $225,000
Emerging Infectious Diseases 2010 NIAID 5R21AI082322-02 Development of an in vivo model of chlamydial persistence. SCHOBORG, ROBERT EAST TENNESSEE STATE UNIVERSITY TN $175,279
Emerging Infectious Diseases 2010 NIAID 5R21AI083520-02 Pre-existing iBALT structures facilitate accelerated humoral immune responses in WILEY, JAMES MONTANA STATE UNIVERSITY (BOZEMAN) MT $178,125
Emerging Infectious Diseases 2010 NIAID 5R21AI081120-02 Elemental imaging of M. tuberculosis during infection. TALAAT, ADEL UNIVERSITY OF WISCONSIN MADISON WI $181,745
Emerging Infectious Diseases 2010 NIAID 5R21AI084094-02 The role of viral infection in prion shedding from olfactory neurons BESSEN, RICHARD MONTANA STATE UNIVERSITY (BOZEMAN) MT $178,125
Emerging Infectious Diseases 2010 NIAID 5R21AI081100-02 A forward genetics screen for genes regulating phagocytosis and signaling in Enta TEMESVARI, LESLY CLEMSON UNIVERSITY SC $185,625
Emerging Infectious Diseases 2010 NIAID 5R21AI081053-02 Mannose Receptor in Ricin Pathogenesis MANTIS, NICHOLAS WADSWORTH CENTER NY $178,811
Emerging Infectious Diseases 2010 NIAID 5R21AI081065-02 Structure and Design of Cytokine and Chemokine Binding Proteins WALTER, MARK UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $188,288
Emerging Infectious Diseases 2010 NIAID 5R21AI073639-02 A novel splice variant of interleukin-13 and its role in promoting EAE responses SHAW, MICHAEL WAYNE STATE UNIVERSITY MI $228,000
Emerging Infectious Diseases 2010 NIAID 5R21AI076889-02 Eukaryotic-type STK/STP-mediated modulation of enterococcal pathogenesis PANCHOLI, VIJAY OHIO STATE UNIVERSITY OH $187,500
Emerging Infectious Diseases 2010 NIAID 5R01AI073718-02 MECHANISMS OF SIGNALING BY ACTIVATING RECEPTORS IN INNATE IMMUNE SYSTEMS CELLS SWAT, WOJCIECH WASHINGTON UNIVERSITY MO $380,000
Emerging Infectious Diseases 2010 NIAID 5R21AI075175-02 The Role of Antibody-Mediated Protective Immunity Against Q fever ZHANG, GUOQUAN UNIVERSITY OF MISSOURI-COLUMBIA MO $180,064
Emerging Infectious Diseases 2010 NIAID 5R03AI076856-02 Determining the reservoir hosts for host-targeted control measures to prevent Lym DIUK-WASSER, MARIA YALE UNIVERSITY CT $82,750
Emerging Infectious Diseases 2010 NIAID 5R21AI081035-02 Regulation of Yersenia pestis virulence genes in response to host cell contact ANDERSON, DEBORAH UNIVERSITY OF MISSOURI-COLUMBIA MO $221,032
Emerging Infectious Diseases 2010 NIAID 5R21AI082919-02 Can persistent gamma-herpesviruses be purged from the host? BLACKMAN, MARCIA TRUDEAU INSTITUTE, INC. NY $235,000
Emerging Infectious Diseases 2010 NIAID 5R21AI083984-02 Membrane Rearrangements in Flavivirus Infected Cells KUHN, RICHARD PURDUE UNIVERSITY WEST LAFAYETTE IN $190,625
Emerging Infectious Diseases 2010 NIAID 5R21AI081111-02 The Role of Lipoarabinomannan in Mycobacterium tuberculosis PARISH, TANYA INFECTIOUS DISEASE RESEARCH INSTITUTE WA $196,500
Emerging Infectious Diseases 2010 NIAID 5R21AI081164-02 Contact Network Epidemiology of Influenza and Other Nosocomial Infections SEGRE, ALBERTO UNIVERSITY OF IOWA IA $183,842
Emerging Infectious Diseases 2010 NIAID 5R21AI083911-02 Regulation of Virus-Specific T cell Responses by TNF BREHM, MICHAEL UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $205,573
Emerging Infectious Diseases 2010 NIAID 5F31AI080160-02 Ecological impacts of forest disturbance on La Crosse encephalitis virus dynamics HARRIS, MARIA-RICHETTA VIRGINIA POLYTECHNIC INST AND ST UNIV VA $30,416
Emerging Infectious Diseases 2010 NIAID 5F32AI081439-02 Investigation of Giardiasis Using Click Chemistry Techniques KORTHALS, KEITH SCRIPPS RESEARCH INSTITUTE CA $50,474
Emerging Infectious Diseases 2010 NIAID 5F31AI084487-02 Role of TRIM proteins in the innate cellular antiviral response to HCV DIMBERU, PENIEL YALE UNIVERSITY CT $41,380
Emerging Infectious Diseases 2010 NIAID 5F32AI080082-02 Viral evasion of global RNA turnover during gammaherpesvirus lytic infection CLYDE, KAREN UNIVERSITY OF CALIFORNIA BERKELEY CA $52,154
Emerging Infectious Diseases 2010 NCRR 3R01AI077690-02S1 Modeling of S.Aureus Transmission in Northern Manhattan LOWY, FRANKLIN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $339,002
Emerging Infectious Diseases 2010 NIAID 5F32AI083029-02 Genetic analysis of the NKT cell response to Streptococcus pneumoniae VELA, JOSE LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $50,474
Emerging Infectious Diseases 2010 NCRR 3R01AI022933-23S1 Genetic Analysis of Salmonella Typhimurium Virulence HEFFRON, FRED OREGON HEALTH AND SCIENCE UNIVERSITY OR $226,604
Emerging Infectious Diseases 2010 NIAID 5R01AI057588-07 The Role of LPS and Toll-like Receptors in Plague LIEN, EGIL UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $415,101
Emerging Infectious Diseases 2010 NIAID 5R21AI071261-02 Disposable Microfluidic Devices for Point of Care Diagnostics KLAPPERICH, CATHERINE BOSTON UNIVERSITY MA $206,375
Emerging Infectious Diseases 2010 NIAID 5R21AI083838-02 Immunogenicity of an Attenuated Listeria monocytogenes Bacteriophage Resistant Mu ORNDORFF, PAUL NORTH CAROLINA STATE UNIVERSITY RALEIGH NC $217,232
Emerging Infectious Diseases 2010 NINDS 5R01NS056376-03 UPTAKE, TRANSPORT, AND SPREAD OF PRIONS HARRIS, DAVID BOSTON UNIVERSITY MEDICAL CAMPUS MA $406,250
Emerging Infectious Diseases 2010 NCI 5R03CA141365-02 Enabling Integration of Local Health Department (LHD) Infrastructure, Community C SHAH, GULZAR NATIONAL ASSN /CNTY/CITY/HLTH/OFFICIALS DC $56,800
Emerging Infectious Diseases 2010 NCI 5R01CA096512-07 Cell model for KSHV infection and genetic manipulation GAO, SHOU-JIANG UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT TX $349,703
Emerging Infectious Diseases 2010 NIAID 5R01AI054830-07 Combatting Quinolone Antimicrobial Resistance ZECHIEDRICH, ELIZABETH BAYLOR COLLEGE OF MEDICINE TX $383,750
Emerging Infectious Diseases 2010 NIAID 5R21AI079617-02 Innate Immune Sensing of Rift Valley Fever Virus HISE, AMY CASE WESTERN RESERVE UNIVERSITY OH $198,538
Emerging Infectious Diseases 2010 NIDA 5R21DA026328-02 Staying Safe: Training IDUs in Strategies to Avoid HIV and HCV Infection MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $187,875
Emerging Infectious Diseases 2010 NIAID 5R21AI073926-02 Integrase-defective lentiviral based influenza vaccines SALVATORE, MIRELLA WEILL MEDICAL COLLEGE OF CORNELL UNIV NY $222,363
Emerging Infectious Diseases 2010 NIAID 5R01AI043643-09 Host and Bacterial Factors in Disease due to H. Pylori EATON, KATHRYN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $369,171
Emerging Infectious Diseases 2010 NCI 5R01CA140445-02 Roles for RCK/DDX6 in hepatitis C virus pathogenesis and hepatocellular carcinoma SARNOW, PETER STANFORD UNIVERSITY CA $298,800
Emerging Infectious Diseases 2010 NIAID 5R01AI080935-02 Impact of Antibiotics and Vaccines on the in vivo Evolution of S. pneumoniae EHRLICH, GARTH ALLEGHENY-SINGER RESEARCH INSTITUTE PA $639,377
Emerging Infectious Diseases 2010 NIAID 5R21AI074834-02 Altered peptide ligands and immunopathogenesis of dengue virus infection IMRIE, ALLISON UNIVERSITY OF HAWAII AT MANOA HI $191,875
Emerging Infectious Diseases 2010 NIAID 5R01AI077629-02 Iron Homeostasis in Salmonella-Host Interactions FANG, FERRIC UNIVERSITY OF WASHINGTON WA $390,000
Emerging Infectious Diseases 2010 NIAID 5R21AI077787-02 Influenza infection of cats LEE, CHANG OHIO STATE UNIVERSITY OH $187,500
Emerging Infectious Diseases 2010 NIAID 5R21AI081015-02 Breath Test for Pseudomonas aeruginosa in CF TIMMINS, GRAHAM UNIVERSITY OF NEW MEXICO NM $225,000
Emerging Infectious Diseases 2010 NIAID 5R01AI075074-02 Activation of Macrophages by Lipoteichoic Acid HASTY, DAVID UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $315,000
Emerging Infectious Diseases 2010 NIAID 5R01AI073204-02 In vivo regulation of M. tuberculosis cell wall lipids RILEY, LEE UNIVERSITY OF CALIFORNIA BERKELEY CA $377,686
Emerging Infectious Diseases 2010 NIAID 5R21AI083908-02 Towards a Molecular Signature of Neutrophil Priming SALOMON, ARTHUR BROWN UNIVERSITY RI $229,166
Emerging Infectious Diseases 2010 NIGMS 5R01GM081575-02 Functional Subdomain Organization of the Recycling Endosome SHEFF, DAVID UNIVERSITY OF IOWA IA $283,994
Emerging Infectious Diseases 2010 NIAID 5R21AI084596-02 A Propagating Chimeric Particle as a Safe Alternative to Live-Attenuated Virus YOUNG, KELLY GLOBAL VACCINES, INC. NC $226,359
Emerging Infectious Diseases 2010 NIGMS 5R01GM047296-18 New metabolic inputs into synthesis of the pyrimidine of thiamine DOWNS, DIANA UNIVERSITY OF WISCONSIN MADISON WI $298,142
Emerging Infectious Diseases 2010 NIAID 5R01AI077791-02 Genetics Modifiers of Anthrax Lethal Toxin Induced Pathophysiology BRADLEY, KENNETH UNIVERSITY OF CALIFORNIA LOS ANGELES CA $375,965
Emerging Infectious Diseases 2010 NIAID 5R01AI052267-07 Inhibition of Microflora-Induced Colitis by NF-kB HORWITZ, BRUCE BRIGHAM AND WOMEN'S HOSPITAL MA $440,400
Emerging Infectious Diseases 2010 NIAID 5R03AI078442-02 Burkholderia: Characterizing Lung Innate Immunity EAVES-PYLES, TONYIA UNIVERSITY OF TEXAS MEDICAL BR GALVESTON TX $75,500
Emerging Infectious Diseases 2010 NIAID 5R01AI081146-02 Dissecting the structure and function of the Pdu microcompartment in Salmonella BOBIK, THOMAS IOWA STATE UNIVERSITY IA $545,728
Emerging Infectious Diseases 2010 NIAID 5R01AI080628-02 Molecular Analysis of the Rip1 Virulence Pathway of M. tuberculosis GLICKMAN, MICHAEL SLOAN-KETTERING INSTITUTE FOR CANCER RES NY $474,750
Emerging Infectious Diseases 2010 NIAID 5R21AI083660-02 Regulation of Yersinia Type III Secretion by YopK MARKETON, MELANIE INDIANA UNIVERSITY BLOOMINGTON IN $218,504
Emerging Infectious Diseases 2010 NIAID 5R21AI083732-02 MYST opportunities for Toxoplasma drug development SULLIVAN JR., WILLIAM INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $230,838
Emerging Infectious Diseases 2010 NIAID 5R21AI083466-02 Innate and adaptive immune responses at the respiratory mucosa THANAVALA, YASMIN ROSWELL PARK CANCER INSTITUTE CORP NY $227,162
Emerging Infectious Diseases 2010 NIAID 5R21AI082484-02 Mycobacterium turberculosis metal transport P-type ATPases ARGUELLO, JOSE WORCESTER POLYTECHNIC INSTITUTE MA $194,561
Emerging Infectious Diseases 2010 NIA 5R01AG029635-02 Therapeutic Monoclonal Antibodies for Human Prion Diseases SADOWSKI, MARTIN NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $380,250
Emerging Infectious Diseases 2010 NIAID 5R21AI081714-02 Genetic adaptation in Campylobacter: mechanisms and impacts on human health LINZ, JOHN MICHIGAN STATE UNIVERSITY MI $182,473
Emerging Infectious Diseases 2010 NCI 5R03CA137729-03 Inhibition of EP1 in conjunction with Sorafenib for liver cancer chemoprevention HAN, CHANG TULANE UNIVERSITY OF LOUISIANA LA $74,548
Emerging Infectious Diseases 2010 NIAID 5R21AI076812-02 Development and Evaluation of a Dual-Antigen Nasal Brucella Vaccine HE, YONGQUN UNIVERSITY OF MICHIGAN AT ANN ARBOR MI $211,619
Emerging Infectious Diseases 2010 NIDDK 5R21DK075857-02 Fibrolytic Activation of Hepatic Stellate Cells by T Cell Derived Microparticles SCHUPPAN, DETLEF BETH ISRAEL DEACONESS MEDICAL CENTER MA $255,000
Emerging Infectious Diseases 2010 NIAID 5R21AI079369-02 A novel cholera subunit vaccine based on 4 colonization factors WADE, WILLIAM DARTMOUTH COLLEGE NH $234,100
Emerging Infectious Diseases 2010 NIAID 5R21AI083475-02 Immune Regulation in the Respiratory Tract by the Epithelial Protein PLUNC COHN, LAUREN YALE UNIVERSITY CT $248,250
1234


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer